SydLab one
unlocking small organisms testing to any lab
ENABLING ETHICAL TESTING. PROVIDING FULL-ORGANISM DATa
the first End-to end automated high-content screening system on full organisms with active flow control
Micro-organisms testing made easy
SydLab One is an easy to design and run experiment platform so you can focus on what is important: your results.
unlocking unique datapoints
By automating end-to-end small organisms experimentation, unprecedented levels of standardization and reproducibility are achieved.
explorethe full solution
SydLab ONE
The sydlab one experience
datapoints like never before
Get quick and accurate data about the effects of your compounds on living systems. Make predictions about their potential impact on animal and human health.
How can SydlAB one help you
Automation of manual protocols
- Elimination of manual worms handling, culture, treatment and monitoring.
- No manual protocols, more time for your research. Faster and better datapoints to top-up your results.
Unique readouts on small organisms
- Thanks to the elimination of manual protocols, SydLab achieves to extract unique readouts unlocking the full potential of C. elegans as the powerful model organism that it is.
Unprecedented scalability
- 1 experiment, 64 parallel conditions tested
- Fully automated treatment and analysis.
Unprecedented reproducibility
- High reproducibility of the analyzed phenotypes, including worms’ growth, reproduction and survival rate.
the trusted partner of researchers
-
Failure in later stages of the R&D pipeline is especially costly. We actively pursue technologies to identify adverse toxicology as early as possible, such as Nagi Bioscience’s technologies.
Early Toxicology Safety – Agrochemical Company
Unfavorable toxicological profiles are a major cause of late failure in our discovery pipelines. Failure in later stages of the R&D pipeline is especially costly. We are actively pursuing technologies to identify adverse toxicology as early as possible, including through the use of model systems such as those being investigated by Nagi Bioscience.
Early Toxicology Safety – Agrochemical Company
-
Methodologies to assess lifespan and healthspan measures in a high-throughput manner are currently inadequate in the C. elegans field. The integration of Nagi’s technology opened many possibilities for us as a company.
CEO – Aging Biotech Company
Before proceeding to clinical trials, the efficacy of our existing drugs or combinations thereof for their positive impact on healthspan will be tested in the nematode C.elegans. However, methodologies to assess lifespan and healthspan measures in a high-throughput manner are currently inadequate in the C. elegans field. The integration of Nagi’s technology into Rejuvenate opened many possibilities for us as a company.
CEO – Aging Biotech Company
welcome to the sydlab™ one universe
